Skip to main content

Venous Thrombosis clinical trials at University of California Health

5 in progress, 3 open to eligible people

Showing trials for
  • BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis

    open to eligible people ages 18 years and up

    The objective of this study is to demonstrate the safety and efficacy of the Indigo Aspiration system for percutaneous mechanical thrombectomy in a population presenting with obstruction due to deep vein thrombosis (DVT) who are eligible for treatment.

    at UCLA

  • Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

    open to eligible people ages 18 years and up

    The purpose of this study is to determine if the use of image-guided, endovascular therapy (EVT) is an effective strategy with which to reduce Post Thrombotic Syndrome (PTS) disease severity and improve quality of life in patients with established disabling iliac-obstructive post thrombotic syndrome (DIO-PTS).

    at UCLA UCSF

  • JETi Peripheral Thrombectomy Registry

    open to eligible people ages 18 years and up

    The JETi Registry is a prospective, multi-center, observational study to collect real-world data on the safety, performance, and clinical benefits of the JETi® Peripheral Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature.

    at UCLA

  • Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

    Sorry, in progress, not accepting new patients

    The overarching objective of the study is to determine the effectiveness of LMWH/ warfarin vs. DOAC anticoagulation for preventing recurrent VTE in cancer patients. The intervention strategy is Direct Oral AntiCoagulants (DOAC) therapy with edoxaban, apixaban, rivaroxaban, or dabigatran. The comparator is low molecular weight heparin (LMWH) alone or with warfarin. The information gained will empower cancer patients and physicians to make more informed choices about anticoagulation strategies to manage VTE.

    at UCSF

  • ClotTriever Outcomes (CLOUT) Registry

    Sorry, in progress, not accepting new patients

    Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.

    at UCLA

Our lead scientists for Venous Thrombosis research studies include .

Last updated: